参考文献/References:
[1]Alba MA,Flores-Suarez LF,Henderson AG,et al.Interstitial lung disease in ANCA vasculitis[J].Autoimmun Rev,2017,16(7):722-729.[2]Oiwa H,Ooi K,Oyama T,et al.Idiopathic Interstitial Pneumonia as a Possible Cause of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis:A Case Report[J].Arch Rheumatol,2018,33(1):89-92.[3]Hosoda C,Baba T,Hagiwara E,et al.Clinical features of usual interstitial pneumonia with antineutrophil cytoplasmic antibody in comparison with idiopathic pulmonaryfibrosis[J].Respirology,2016,21(5):920-926.[4]TravisWD,Leslie KO,Beasley MB.Pulmonary vasculitis and pulmonary hemorrhage[J].Practical Pulmonary Pathology,2018(4):365-400.[5]Flores-Suárez,Luis Felipe,Alba MA,et al.Pulmonary Involvement in Systemic Vasculitis[J].Current Rheumatology Reports,2017,19(9):56.[6]Cordier JF,Cottin V.Alveolar hemorrhage in vasculitis: primary and secondary[J].Semin Respir Crit Care Med,2011,32(3):310-321.[7]Xian H,Hu P,Flak RJ,et al.Overview of the pathogens is of ANCA-associated vasculitis[J].Kideny Dis(Basel),2016(1):205-215. [8]Brown AN,Strange C.Connective Tissue Disease and Vasculitis-Associated Interstitial Lung Disease[M]//Pulmonary Arterial Hypertension and Interstitial Lung Diseases.Humana Press,2009.[9]Muniz VS,Silva JC,Braga YAV,et al.Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus[J].Allergy Clin Immunol,2018,141(2):571-585. [10]Hartl D.Macrophages and platelets join forces to release kidney-damaging DNA traps[J].Nature Medicine,2018,24(2):128-129.[11]Doring Y,Soehnlein O,Weber C.Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis[J].Circulation Research,2017,120(4):736-743.[12]Hasegawa J,Wakai S,Kono M,et al.An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody(MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys,Skin,and Gastrointestinal Tract[J].Intern Med,2018,57(18):2739-2745.[13]Takeuchi H,Kawasaki T,Shigematsu K,et al.Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis[J].Clinical Rheumatology,2017,36(4):913-917.[14]Perez-Sanchez C,Aguirre M,Galindo-Izquierdo M,et al.AB0165 Regulation of Atherothrombosis in Systemic Lupus Erythematosus. Role of Different Monocyte Subsets,Netosis Involvement,and Effects of Anti-Dsdna Antibodies[J].Annals of the Rheumatic Diseases,2015,74(Suppl 2):945.[15]何倩.抗中性粒细胞胞浆髓过氧化物酶抗体相关性血管炎（MPO-AAV）患者外周血中性粒细胞外捕网水平的变化及意义[D].安徽医科大学,2018.[16]Haozhe Q,Shuofei Y,Lan Z.Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis[J].Frontiers in Immunology,2017,8(1):928.[17]Miao D,Li DY,Chen M,et al.Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway[J].Arthritis Research&Therapy,2017,19(1):252. [18]Hao J,Chen M,Zhao MH.Involvement of protein kinase C in C5a-primed neutrophils for ANCA-mediated activation[J].Molecular Immunology,2013,54(1):68-73.[19]Smith ML.Pathology of antineutrophil cytoplasmic antibody-associated pulmonary and renal disease[J].Arch Pathol Lab,2017(141):223-231.[20]Travis WD,Hoffman GS,Leavitt RY,et al.Surgical Pathology of the Lung in Wegeners Granulomatosis[J].American Journal of Surgical Pathology,1991,15(4):315-333.[21]Reynolds HY.Inflammation and fibrosis[J]. Hepatology,2013,58(S1):281A-284A.[22]Ishizaki J,Takemori A,Suemori K,et al.Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis[J].Arthritis Research&Therapy,2017,19(1):218.[23]Tsicopoulos A,Chang Y,Ait YS,et al.Role of CCL18 in asthma and lung immunity[J].Clinical&Experimental Allergy,2013,43(7):716-722.[24]孙忻,高粹,黄警,等.肺间质病患者血清抗中性粒细胞胞质抗体阳性的临床意义及研究进展[J].中华呼吸与结核,2019,7(42):526-529.[25]Morovic-Vergles J,Culo MI,Sutic A.Clinical manifestations of antineutrophil cytoplasmic antibodies associated vasculitis[J].Lijeccniccki Vjesnik,2014,136(7-8):228-231.[26]Cartin-Ceba R,Diaz-Caballero L,Al-Qadi MO,et al.Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis:Predictors of Respiratory Failure and Clinical Outcomes[J].Arthritis&Rheumatology,2016,68(6):1467-1476.[27]林志谦,许建荣,程杰军,等.ANCA相关性小血管炎的胸部高分辨CT表现[J].医学影像学杂志,2010,20(6):817-819.[28]Martinez FJ,Chisholm A,Collard HR,et al.The diagnosis of idiopathic pulmonary fibrosis: current and future approaches[J].The Lancet Respiratory Medicine,2017,5(1):61-71.[29]Yamagata M,Ikeda K,Tsushima K,et al.Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis:A Multicenter,Longitudinal,Retrospective Study of One Hundred Fifty Consecutive Hospital-Based Japanese Patients[J].Arthritis&Rheumatology,2016,68(3):713-723.[30]戴启春,胡粟,刘运练,等.显微镜下多血管炎肺损害的CT表现[J].临床放射学杂志,2013,32(11):1576-1579.[31]WangChrong-Reen,Tsai Yi-Shan,Tsai Hung-Wen.Acute Myocarditis in Patients with Antineutrophil Cytoplasmic Antibody-positive Microscopic Polyangiitis and Receiving Rituximab Therapy[J].The Journal of rheumatology,2019(12):1645-1646.[32]Shi L.Anti-neutrophil cytoplasmic antibody-associated vasculitis:prevalence,treatment,and outcomes[J].Rheumatology International,2017,37(11):1779-1788.[33]牟茂婷,杨爽,彭兰驭,等.抗中性粒细胞浆抗体相关性血管炎治疗研究进展[J].临床合理用药杂志,2019,12(10):176-177.[34]McBrien CN,Menzies-Gow A.Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis[J].Drugs Today (Barc),2018,54(2):93-101.[35]Wechsler ME,Akuthota P,Jayne D,et al.Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis[J].New England Journal of Medicine,2017,376(20):1921-1932.[36]Holle JU,Dubrau C,Herlyn K,et al.Rituximab for refractory granulomatosis with polyangiitis(Wegener\"s granulomatosis):comparison of efficacy in granulomatous versus vasculitic manifestations[J].Annals of the Rheumatic Diseases,2012,71(3):327-333.[37]Nathan SD,Albera C,Bradford WZ,et al.Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis[J].The Lancet Respiratory Medicine,2016,5(1):33-41.